NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Obesity, Fitness & Wellness Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity, Fitness & Wellness Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Germ Cell Cancer



Survivors of rare ovarian cancer retain fertility, have positive relationships, study finds



July 14th, 2007

Ovarian germ cell tumor patients treated with platinum-based chemotherapy and fertility-sparing surgery are likely to retain their menstrual function and reproductive ability, according to the largest and most comprehensive survey of survivors ever conducted.

The new prospective study, published in the July 1 issue of the Journal of Clinical Oncology and conducted by The University of Texas M. D. Anderson Cancer Center and the Gynecologic Oncology Group, also found that despite having reproductive and sexual concerns, survivors were more likely than their healthy counterparts to be involved in meaningful, positive relationships.

Ovarian cancer is...


Source: Obesity, Fitness & Wellness Week (2007-07-14)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login